Greenfield Seitz Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$347K Sell
7,195
-525
-7% -$24.5K 0.1% 90
2025
Q4
$374K Sell
7,720
-1,560
-17% -$77.3K 0.12% 87
2025
Q3
$438K Sell
9,280
-1,900
-17% -$91.7K 0.14% 81
2025
Q2
$540K Sell
11,180
-55
-0.5% -$2.81K 0.19% 72
2025
Q1
$623K Hold
11,235
0.24% 70
2024
Q4
$542K Buy
11,235
+470
+4% +$23.9K 0.21% 72
2024
Q3
$620K Sell
10,765
-1,035
-9% -$55.9K 0.23% 72
2024
Q2
$573K Sell
11,800
-610
-5% -$29.4K 0.21% 73
2024
Q1
$603K Sell
12,410
-600
-5% -$29.3K 0.22% 72
2023
Q4
$647K Buy
+13,010
New +$636K 0.26% 73

Other funds holding SNY

Greenfield Seitz Capital Management's SNY Position: Q1 2026 in Review

Greenfield Seitz Capital Management reduced its Sanofi (SNY) stake by 6.8% in Q1 2026, selling an estimated $24.5K and leaving 7,195 shares worth $347K. The position accounts for 0.1% of the portfolio, ranked #90.

Greenfield Seitz Capital Management first reported a position in SNY in Q4 2023 and has held it in 10 quarters since. The position peaked at $647K in Q4 2023. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Greenfield Seitz Capital Management held 7,195 shares of Sanofi worth $347K as of Q1 2026.
  • Greenfield Seitz Capital Management sold 525 Sanofi shares in Q1 2026, an estimated $24.5K.
  • Sanofi made up 0.1% of Greenfield Seitz Capital Management's portfolio in Q1 2026, its #90 holding.
  • Greenfield Seitz Capital Management first reported a position in Sanofi in Q4 2023 and has held it in 10 quarters since.
  • Greenfield Seitz Capital Management's Sanofi position peaked at $647K in Q4 2023.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Greenfield Seitz Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.